Xoma | XOMA - Current Liabilities

Stock Price
25.81
Daily Change
1.41 5.78%
Monthly
-5.35%
Yearly
9.74%
Q1 Forecast
25.01

Xoma reported $28.3M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
AbbVie USD 43.29B 3.9B Dec/2025
Agenus USD 287.13M 52.57M Sep/2025
Agios Pharmaceuticals USD 82.21M 7.45M Dec/2025
Ardelyx USD 83.39M 1.67M Sep/2025
aTyr Pharma USD 15.68M 148K Sep/2025
BioMarin Pharmaceutical USD 798.44M 114.19M Sep/2025
Celldex Therapeutics USD 46.46M 13.5M Sep/2025
Curis USD 19.37M 745K Jun/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Emergent BioSolutions USD 651.3M 12.7M Dec/2023
Incyte USD 1.52B 176.44M Dec/2025
MacroGenics USD 44.47M 5.47M Sep/2025
Novartis USD 32B 286M Sep/2025
Novartis USD 32B 286M Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Prothena USD 51.44M 16.37M Sep/2025
Regeneron Pharmaceuticals USD 4.37B 56.7M Dec/2025
Xoma USD 28.3M 6.81M Sep/2025